Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Antiretroviral Drugs
Pharma
ViiV girds data package for Cabenuva in competitive HIV market
Cabenuva hit superior viral suppression versus oral antiretrovirals in adults and adolescents with HIV-1 with viremia in the phase 3b Crown study.
Fraiser Kansteiner
Oct 6, 2026 10:59am
Merck prepares expanded access to monthly PrEP pill early
Jul 24, 2026 10:40am
Gilead, Merck phase 3 data back first weekly HIV pill
Jul 21, 2026 10:00am
Gilead's bictegravir, lenacapavir tablet meets mark in phase 3
Nov 13, 2025 9:55am
Gilead's PrEP shows early promise in once-yearly dosing
Mar 11, 2025 2:30pm
GSK's Dovato matches Gilead's Biktarvy with less weight gain
Jul 23, 2024 4:00am